Grants
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) (PAR-24-043)
Sponsor
National Institutes of Health
Due Date
Multiple due dates; see announcement.